# Chapter 3: Choose My Pharmacy® Core Measure Set



# Seguridad Health Measures®

<table border="1" cellpadding="0" cellspacing="0" class="MsoTableGrid" id="bkmrk-title-description-pe" style="border-collapse: collapse; border: none; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0in 5.4pt 0in 5.4pt;"><tbody><tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150">**<span style="font-size: 11.0pt;">Title</span>**

</td><td style="width: 247.5pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330">**<span style="font-size: 11.0pt;">Description</span>**

</td><td style="width: 107.75pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144">**<span style="font-size: 11.0pt;">Performance</span>**

</td></tr><tr style="mso-yfti-irow: 1;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Assessment of Renal Function in Older Adults</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients aged 65 years and older with a serum creatine on file at the pharmacy during the measurement year</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 2;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Assessment of Weights in Pediatrics</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of pediatric patients (17 years and less) with an updated weight during the measurement year</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 3;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Known Allergy Status</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patient records with documented allergy status, including ‘no known drug allergies’.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 4;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Medication Indication</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of electronic prescriptions with *prescriber-reported* indication based on International Classification of Disease – 10</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144">**<span style="font-size: 11.0pt;">This is a reporting measure only</span>**

</td></tr><tr style="mso-yfti-irow: 5;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Electronic Care Plan Accessibility</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Possession of e-care plan with appropriate training</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 6;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Point of Care Testing Structure</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Possession of a CLIA-waiver in the pharmacy.</span>

<span style="font-size: 11.0pt;"> </span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 7;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Employee Vaccination Rate</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of employees in a pharmacy that are vaccinated for influenza and COVID-19.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 8;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Advanced Pharmacy Technicians</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of pharmacy technicians with advance training</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 9;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Improving Pain Management Safety</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of households at risk for opioid adverse event with naloxone available</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 10;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Improving Diabetes Safety</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients with high-risk diabetes with glucagon available.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr><tr style="mso-yfti-irow: 11; mso-yfti-lastrow: yes;"><td style="width: 112.25pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="150"><span style="font-size: 11.0pt;">Identify Social Determinants of Health</span>

</td><td style="width: 247.5pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="330"><span style="font-size: 11.0pt;">Percent of patients with documented demographic information.</span>

</td><td style="width: 107.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0in 5.4pt 0in 5.4pt;" valign="top" width="144"><span style="font-size: 11.0pt;">A higher rate is better</span>

</td></tr></tbody></table>